A Look Into Healthcare Sector Value Stocks
Portfolio Pulse from Benzinga Insights
Benzinga Insights identifies five healthcare sector value stocks with low P/E ratios, suggesting they may be undervalued: Exicure (XCUR), Spok Holdings (SPOK), Palisade Bio (PALI), Zymeworks (ZYME), and Agile Therapeutics (AGRX). The article provides recent earnings per share (EPS) data for these companies, noting changes from previous quarters.
January 22, 2024 | 2:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Agile Therapeutics has the lowest P/E at 0.2, with a substantial improvement in Q3 EPS from -3.1 to $-1.47.
The extremely low P/E ratio combined with the significant improvement in EPS strongly suggests undervaluation, which could lead to a sharp short-term price increase as investors recognize the value.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90
POSITIVE IMPACT
Palisade Bio's P/E is 1.67 with a recent EPS of $-0.49, an improvement from $-0.53 in Q2.
The improvement in EPS and low P/E ratio indicate that Palisade Bio could be undervalued, which might lead to a positive short-term price movement as investors take notice.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 80
POSITIVE IMPACT
Exicure has a P/E of 0.34 and reported an improved Q2 EPS of $-0.68, up 2.86% from Q1.
The low P/E ratio and improved EPS suggest that Exicure may be undervalued, which could lead to increased investor interest and a potential short-term price increase.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Zymeworks has a P/E of 3.05 and reported a better EPS of $-0.38 compared to $-0.75 in Q2.
The significant improvement in EPS and low P/E ratio suggest that Zymeworks may be undervalued, which could result in a positive short-term price trend.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Spok Holdings has a P/E of 8.57, a slight decrease in EPS, and a dividend yield decrease to 8.6% from 10.82%.
While the slight decrease in EPS and dividend yield might concern investors, the low P/E ratio could still indicate the stock is undervalued, leading to a neutral short-term impact.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70